查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1529675

食物過敏診斷和治療市場規模、佔有率和趨勢分析報告：按產品、過敏原原料、最終用途、地區、細分市場預測，2024-2030年

Food Allergy Diagnostics And Therapeutics Market Size, Share & Trends Analysis Report By Product (Diagnostics, Therapeutics), By Allergen Source, By End-use, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

食物過敏診斷和治療市場的成長和趨勢：

根據Grand View Research, Inc.最新報告，預計到2030年，全球食物過敏診斷和治療市場規模將達到132.8億美元，預測期內複合年成長率為8.0%。

由於食物過敏的盛行率不斷上升以及對管理這些疾病的產品的需求不斷成長，預計未來幾年該市場將成長。

PEG最大的應用是醫療，到2022年將佔40%以上的市場佔有率。 PEG 優異的混合性、吸濕性和無毒特性使其在錠劑和軟膏等眾多醫藥產品中具有很高的需求。不斷成長的醫藥支出，尤其是印度、中國和巴西等新興國家的醫藥支出，預計將在預測期內提振 PEG 市場。對油漆和塗料的需求不斷增加，加上由於揮發性有機化合物排放低而擴大使用聚乙二醇作為溶劑，預計將在未來六年推動市場成長。

然而，在過敏反應的早期階段使用自動注射器注射腎上腺素可以預防嚴重的併發症。美國每年花費約 250 億美元治療食物過敏。開發具有成本效益的體外診斷測試來檢測過敏預計將推動對診斷產品的需求。

食物過敏診斷和治療市場報告亮點

  • 由於抗組織胺和腎上腺素自動注射器的需求不斷增加，治療藥物領域將在 2023 年佔據市場主導地位。
  • 診斷細分市場包括設備、耗材和服務，耗材預計在預測期內將以最快的複合年成長率成長。
  • 最常用於診斷食物過敏的檢查是皮膚點刺測試和血液檢查。
  • 由於新產品的推出以及世界範圍內花生過敏患病率的上升，預計花生過敏原成分領域將在預測期內出現良好的成長。
  • 由於嚴重過敏症狀住院患者數量增加，2023年食物過敏診斷和治療市場以醫院和診所為主。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第3章食物過敏診斷和治療市場變數、趨勢和範圍

  • 市場介紹/系統展望
  • 市場規模及成長前景
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 食物過敏診斷與治療市場分析工具
    • 波特的分析
    • PESTEL分析

第4章食物過敏診斷和治療市場：按產品估計和趨勢分析

  • 細分儀表板
  • 食物過敏診斷與治療市場：2023 年和 2030 年按產品分類的變化分析
  • 診斷
  • 治療

第5章食物過敏診斷及治療市場：依過敏原原料估算及趨勢分析

  • 細分儀表板
  • 食物過敏診斷與治療市場：2023 年和 2030 年過敏原來源分析
  • 花生
  • 牛奶
  • 蛋
  • 魚
  • 貝類
  • 堅果
  • 小麥
  • 大豆
  • 其他

第6章食物過敏診斷和治療市場：最終用途的估計和趨勢分析

  • 細分儀表板
  • 食物過敏診斷和治療市場：2023 年和 2030 年最終用途的變化分析
  • 醫院和診所
  • 學術研究所
  • 診斷實驗室

第7章食物過敏診斷和治療市場：區域估計和趨勢分析

  • 2023 年和 2030 年食物過敏診斷和治療市場佔有率（按地區）
  • 北美洲
    • 2018-2030年北美食物過敏診斷與治療市場估計與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 2018-2030年歐洲食物過敏診斷與治療市場估計與預測
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 2018-2030年亞太地區食物過敏診斷與治療市場估計與預測
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 2018-2030年拉丁美洲食物過敏診斷與治療市場估計與預測
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 中東和非洲食物過敏診斷和治療市場估計和預測，2018-2030
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非
    • 科威特

第8章 競爭格局

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司分類
  • 企業熱力圖分析
  • 公司簡介
    • Allergy Therapeutics
    • Cambridge Allergy Limited
    • Astellas Pharma, Inc
    • Immunomic Therapeutics, Inc
    • Prota Therapeutics Pty Ltd
    • Aimmune Therapeutics
    • Meridian Medical Technologies
    • ALK-Abello Ltd
    • Medeca Pharma AB
    • bioMerieux SA
    • Omega Diagnostics Group PLC
    • HYCOR Biomedical
    • HOB Biotech Group PLC
簡介目錄
Product Code: GVR-3-68038-746-9

Food Allergy Diagnostics And Therapeutics Market Growth & Trends:

The global food allergy diagnostics and therapeutics market size is expected to reach USD 13.28 billion by 2030, registering a CAGR of 8.0% during the forecast period, according to a new report by Grand View Research, Inc. The market is expected to grow in the coming years owing to increasing incidence of food allergies coupled with rising demand for products for management of these conditions.

Medical was the largest application for PEG, accounting for more than 40% of market share in 2022. Superior blending, hygroscopicity, and non-toxic properties of PEG have resulted in high demand for the chemical in numerous pharmaceutical products such as tablets and ointments. Increasing pharmaceutical expenditure, particularly in emerging economies of India, China, and Brazil, is expected to boost PEG market over the forecast period. Growing demand for paints & coatings coupled with the increasing use of PEG as a solvent due to its low VOC emissions is anticipated to fuel market growth over the next six years.

However, administering epinephrine using an auto-injector during the early stage of anaphylaxis might help avoid any serious complications. Treatment for food allergy costs around USD 25 billion annually in the U.S. Development of cost-effective in vitro diagnostic tests for detection of allergy is expected to fuel the demand for diagnostic products.

Food Allergy Diagnostics And Therapeutics Market Report Highlights:

  • Therapeutics segment dominated the market in 2023 due to growing demand for antihistamines and epinephrine auto-injector
  • Diagnostic segment includes instruments, consumables, and services, wherein consumables expected to grow at the fastest CAGR during the forecast period
  • The most common tests used to diagnose food allergies are skin prick tests and blood tests
  • Peanut allergen source segment is anticipated to register lucrative growth over the forecast period, owing to novel product launches coupled with rising incidence of peanut allergies worldwide.
  • Hospitals & clinics dominated the food allergy diagnostics & therapeutics market in 2023 owing to increase in number of hospitalizations due to severe allergic conditions

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Food Allergy Diagnostics and Therapeutics Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Billion)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. Food Allergy Diagnostics and Therapeutics Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. Food Allergy Diagnostics and Therapeutics Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Food Allergy Diagnostics and Theraoeutics Market: Product Movement Analysis, 2023 & 2030 (USD Million)
  • 4.3. Diagnostics
    • 4.3.1. Diagnostics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.2. Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.3. Consumables Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.4. Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.5. Tests Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Therapeutics
    • 4.4.1. Therapeutics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.2. Antihistamines Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.3. Epinephrine Auto-injector Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Food Allergy Diagnostics and Therapeutics Market: Allergen Source Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Food Allergy Diagnostics and Therapeutics Market: Allergen Source Analysis, 2023 & 2030 (USD Million)
  • 5.3. Peanuts
    • 5.3.1. Peanuts Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Milk
    • 5.4.1. Milk Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Eggs
    • 5.5.1. Eggs Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Fish
    • 5.6.1. Fish Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7. Shellfish
    • 5.7.1. Shellfish Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.8. Tree Nuts
    • 5.8.1. Tree Nuts Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.9. Wheat
    • 5.9.1. Wheat Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.10. Soy
    • 5.10.1. Soy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.11. Others
    • 5.11.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Food Allergy Diagnostics and Therapeutics Market: End use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Food Allergy Diagnostics and Therapeutics Market: End use Movement Analysis, 2023 & 2030 (USD Million)
  • 6.3. Hospitals and Clinics
    • 6.3.1. Hospitals And Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Academic Research Institutes
    • 6.4.1. Academic Research Institutes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Diagnostics Laboratories
    • 6.5.1. Diagnostics Laboratories Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 7. Food Allergy Diagnostics and Therapeutics Market: Regional Estimates & Trend Analysis

  • 7.1. Food Allergy Diagnostics and Therapeutics Market Share, By Region, 2023 & 2030 (USD Million)
  • 7.2. North America
    • 7.2.1. North America Food Allergy Diagnostics and Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.2. U.S.
      • 7.2.2.1. U.S. Food Allergy Diagnostics and Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.3. Canada
      • 7.2.3.1. Canada Food Allergy Diagnostics and Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.4. Mexico
      • 7.2.4.1. Mexico Food Allergy Diagnostics and Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.3. Europe
    • 7.3.1. Europe Food Allergy Diagnostics and Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.2. UK
      • 7.3.2.1. UK Food Allergy Diagnostics and Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.3. Germany
      • 7.3.3.1. Germany Food Allergy Diagnostics and Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.3.4. France
      • 7.3.4.1. France Food Allergy Diagnostics and Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.5. Spain
      • 7.3.5.1. Spain Food Allergies Diagnostics and Therapeutics Market Estimation and Forecast, 2018 - 2030 (USD Million)
    • 7.3.6. Denmark
      • 7.3.6.1. Denmark Food Allergies Diagnostics and Therapeutics Market Estimation and Forecast, 2018 - 2030 (USD Million)
    • 7.3.7. Sweden
      • 7.3.7.1. Sweden Food Allergies Diagnostics and Therapeutics Market Estimation and Forecast, 2018 - 2030 (USD Million)
    • 7.3.8. Norway
      • 7.3.8.1. Norway Food Allergies Diagnostics and Therapeutics Market Estimation and Forecast, 2018 - 2030 (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. Asia Pacific Food Allergy Diagnostics and Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.2. China
      • 7.4.2.1. China Food Allergy Diagnostics and Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.3. Japan
      • 7.4.3.1. Japan Food Allergy Diagnostics and Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.4. India
      • 7.4.4.1. India Food Allergy Diagnostics and Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.5. South Korea
      • 7.4.5.1. South Korea Food Allergy Diagnostics and Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.6. Australia
      • 7.4.6.1. Australia Food Allergy Diagnostics and Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.7. Thailand
      • 7.4.7.1. Thailand Food Allergies Diagnostics and Therapeutics Market Estimation and Forecast, 2018 - 2030 (USD Million)
  • 7.5. Latin America
    • 7.5.1. Latin America Food Allergy Diagnostics and Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.2. Brazil
      • 7.5.2.1. Brazil Food Allergy Diagnostics and Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.3. Argentina
      • 7.5.3.1. Argentina Food Allergies Diagnostics and Therapeutics Market Estimation and Forecast, 2018 - 2030 (USD Million)
  • 7.6. Middle East and Africa
    • 7.6.1. Middle East and Africa Food Allergy Diagnostics and Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.2. Saudi Arabia
      • 7.6.2.1. Saudi Arabia Food Allergy Diagnostics and Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.3. UAE
      • 7.6.3.1. UAE Food Allergy Diagnostics and Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.4. South Africa
      • 7.6.4.1. South Africa Food Allergy Diagnostics and Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.5. Kuwait
      • 7.6.5.1. Kuwait Food Allergies Diagnostics and Therapeutics Market Estimation and Forecast, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis by Key Market Participants
  • 8.2. Company Categorization
  • 8.3. Company Heat Map Analysis
  • 8.4. Company Profiles
    • 8.4.1 Allergy Therapeutics
      • 8.4.1.1. Participant's Overview
      • 8.4.1.2. Financial Performance
      • 8.4.1.3. Product Benchmarking
      • 8.4.1.4. Recent Developments/ Strategic Initiatives
    • 8.4.2. Cambridge Allergy Limited
      • 8.4.2.1. Participant's Overview
      • 8.4.2.2. Financial Performance
      • 8.4.2.3. Product Benchmarking
      • 8.4.2.4. Recent Developments/ Strategic Initiatives
    • 8.4.3. Astellas Pharma, Inc
      • 8.4.3.1. Participant's Overview
      • 8.4.3.2. Financial Performance
      • 8.4.3.3. Product Benchmarking
      • 8.4.3.4. Recent Developments/ Strategic Initiatives
    • 8.4.4. Immunomic Therapeutics, Inc
      • 8.4.4.1. Participant's Overview
      • 8.4.4.2. Financial Performance
      • 8.4.4.3. Product Benchmarking
      • 8.4.4.4. Recent Developments/ Strategic Initiatives
    • 8.4.5. Prota Therapeutics Pty Ltd
      • 8.4.5.1. Participant's Overview
      • 8.4.5.2. Financial Performance
      • 8.4.5.3. Product Benchmarking
      • 8.4.5.4. Recent Developments/ Strategic Initiatives
    • 8.4.6. Aimmune Therapeutics
      • 8.4.6.1. Participant's Overview
      • 8.4.6.2. Financial Performance
      • 8.4.6.3. Product Benchmarking
      • 8.4.6.4. Recent Developments/ Strategic Initiatives
    • 8.4.7. Meridian Medical Technologies
      • 8.4.7.1. Participant's Overview
      • 8.4.7.2. Financial Performance
      • 8.4.7.3. Product Benchmarking
      • 8.4.7.4. Recent Developments/ Strategic Initiatives
    • 8.4.8. ALK-Abello Ltd
      • 8.4.8.1. Participant's Overview
      • 8.4.8.2. Financial Performance
      • 8.4.8.3. Product Benchmarking
      • 8.4.8.4. Recent Developments/ Strategic Initiatives
    • 8.4.9. Medeca Pharma AB
      • 8.4.9.1. Participant's Overview
      • 8.4.9.2. Financial Performance
      • 8.4.9.3. Product Benchmarking
      • 8.4.9.4. Recent Developments/ Strategic Initiatives
    • 8.4.10. bioMerieux SA
      • 8.4.10.1. Participant's Overview
      • 8.4.10.2. Financial Performance
      • 8.4.10.3. Product Benchmarking
      • 8.4.10.4. Recent Developments/ Strategic Initiatives
    • 8.4.11. Omega Diagnostics Group PLC
      • 8.4.11.1. Participant's Overview
      • 8.4.11.2. Financial Performance
      • 8.4.11.3. Product Benchmarking
      • 8.4.11.4. Recent Developments/ Strategic Initiatives
    • 8.4.12. HYCOR Biomedical
      • 8.4.12.1. Participant's Overview
      • 8.4.12.2. Financial Performance
      • 8.4.12.3. Product Benchmarking
      • 8.4.12.4. Recent Developments/ Strategic Initiatives
    • 8.4.13. HOB Biotech Group PLC
      • 8.4.13.1. Participant's Overview
      • 8.4.13.2. Financial Performance
      • 8.4.13.3. Product Benchmarking
      • 8.4.13.4. Recent Developments/ Strategic Initiatives